Study finds 2 new drugs are highly effective in treating Ebola
Preliminary results show that two new Ebola drugs appear to be highly effective when it comes to treating people with the virus.
Scientists studied four experimental drugs, and found that a compound developed by Regeneron Pharmaceuticals and another created by the U.S. National Institutes of Health (NIH) "may be able to improve the survival of people with Ebola," Dr. Anthony Fauci of the NIH told The Associated Press.
The drugs are both antibodies that block the virus, and researchers found a mortality rate of 30 percent for those who received the treatments; the mortality rate for another drug, ZMapp, was 50 percent. When patients received the treatments earlier, mortality rates dropped to 6 percent with the Regeneron drug and 11 percent with the NIH compound, compared to 24 percent with ZMapp.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Over the last year, Ebola has killed more than 1,800 people in Congo, and all treatment centers in the country now have access to these two drugs. "Getting people into care more quickly is absolutely vital," Dr. Michael Ryan of the World Health Organization told AP. "The fact that we have very clear evidence now on the effectiveness of the drugs, we need to get that message out to communities."
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Create an account with the same email registered to your subscription to unlock access.
Catherine Garcia is night editor for TheWeek.com. Her writing and reporting has appeared in Entertainment Weekly and EW.com, The New York Times, The Book of Jezebel, and other publications. A Southern California native, Catherine is a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
Magazine interactive crossword - April 26, 2024
Puzzles and Quizzes Issue - April 26, 2024
By The Week US Published
-
Magazine solutions - April 26, 2024
Puzzles and Quizzes Issue - April 26, 2024
By The Week US Published
-
Magazine printables - April 26, 2024
Puzzles and Quizzes Issue - April 26, 2024
By The Week US Published
-
Trump criminal trial starts with rulings, reminder
Speed Read The first day of his historic trial over hush money payments was mostly focused on jury selection
By Rafi Schwartz, The Week US Published
-
Parents of school shooter sentenced to 10-15 years
Speed Read Jennifer and James Crumbley are the first parents to be convicted in a US mass shooting
By Peter Weber, The Week US Published
-
Unlicensed dealers and black market guns
Speed Read 68,000 illegally trafficked guns were sold in a five year period, said ATF
By Peter Weber, The Week US Published
-
Bankman-Fried gets 25 years for fraud
Speed Read Former "crypto king" Sam Bankman-Fried will report to federal prison
By Peter Weber, The Week US Published
-
Feds raid Diddy homes in alleged sex trafficking case
Speed Read Homeland Security raided the properties of hip hop mogul Sean "Diddy" Combs
By Peter Weber, The Week US Published
-
'Goon Squad' cops sentenced for torturing 2 Black men
Speed Read The former Mississippi law enforcement officers pleaded guilty last year
By Peter Weber, The Week US Published
-
Michigan shooter's dad guilty of manslaughter
speed read James Crumbley failed to prevent his son from killing four students at Oxford High School in 2021
By Peter Weber, The Week US Published
-
Shooting at Chiefs victory rally kills 1, injures 21
Speed Read Gunfire broke out at the Kansas City Chiefs' Super Bowl victory parade in Missouri
By Peter Weber, The Week US Published